Volume 44, Issue 1, Pages 9-16 (October 2011)

Slides:



Advertisements
Similar presentations
Apoptosis By Douglas R. Green
Advertisements

Signaling to PROGRAM cell death (Apoptosis) Apoptosis is a cell mechanism used to eliminate cells that are unnecessary to or that contain mutations that.
Apoptosis By Dr Abiodun Mark .A.
Apoptosis is only one form of programmed cell death.
“Cutting Edge” Cancer Research Guy Salvesen, PhD.
Death and Rescue Regulation of cardiac myocyte cell death Lin GH.
Programmed cell Death سخنران : آقای محسن نجاری کارشناس ارشدآزمایشگاه انگل شناسی بیمارستان قائم ( عج )
Apoptosis Yasir Waheed. The cells of a multicellular organism are members of a highly organized community. The number of cells in this community is tightly.
Purposes Of Apoptosis Eliminate cells not needed by organism During development: sculpting, remove excess neurons Adult –Maintain tissue size –Eliminate.
APOPTOSIS Chapter 18 Lecture 23 BMB 252H Lecture by Garam Han
APOPTOSIS In the human body about 100,000 cells are produced every second by mitosis and a similar number die by apoptosis !!!
Programmed Cell Death Programmed Cell Death
Causes, effects and molecular mechanisms of testicular heat stress
Cellular and Molecular Mechanisms of Liver Injury
S Braun, N Gaza, R Werdehausen, H Hermanns, I Bauer, M. E. Durieux, M
Volume 35, Issue 3, Pages (August 2009)
Cellular and Molecular Mechanisms of Liver Injury
Nader Yatim, Matthew L. Albert  Immunity 
Apoptosis: the ‘extrinsic’ and ‘intrinsic’ pathways to caspase activation. Apoptosis: the ‘extrinsic’ and ‘intrinsic’ pathways to caspase activation. Two.
How cells die: Apoptosis pathways
Surviving the Cytochrome Seas
Endoplasmic reticulum stress in liver disease
Volume 47, Issue 2, Pages (July 2012)
Mechanism and Regulation of NLRP3 Inflammasome Activation
On the TRAIL to Overcome BRAF-Inhibitor Resistance
Pseudokiller, Qu’est-ce que C’est?
The BCL-2 Family Reunion
Volume 8, Issue 3, Pages (September 2001)
The Two Faces of Receptor Interacting Protein Kinase-1
The Many Roles of FAS Receptor Signaling in the Immune System
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Apoptosis-targeted therapies for cancer
Keratinocyte Apoptosis in Epidermal Development and Disease
Death Becomes Us: Apoptosis and Carcinogenesis
Life after MOMP Molecular Cell
The CULt of Caspase-8 Ubiquitination
Staying Alive: Cell Death in Antiviral Immunity
Eukaryotic Transcription Activation: Right on Target
Joshua E. Allen, Wafik S. El-Deiry  Gastroenterology 
Douglas R. Green, Beth Levine  Cell 
Lucifer's Labyrinth—Ten Years of Path Finding in Cell Death
Survival Function of the FADD-CASPASE-8-cFLIPL Complex
Hip1 and Hippi Participate in a Novel Cell Death-Signaling Pathway
Volume 102, Issue 1, Pages 1-4 (July 2000)
Bax Activation and Induction of Apoptosis in Human Keratinocytes by the Protein Kinase C δ Catalytic Domain  Leonid A. Sitailo, Shalini S. Tibudan, Mitchell.
An Inflammatory Perspective on Necroptosis
A matter of life and death
The Chemical Biology of Apoptosis
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Death receptor-mediated apoptosis and the liver
Transferring Death: A Role for tRNA in Apoptosis Regulation
Caspases and Kinases in a Death Grip
Roles of Caspases in Necrotic Cell Death
Apoptosis-targeted therapies for cancer
Manipulation of Host Cell Death Pathways during Microbial Infections
Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Arnaud Autret, Seamus J. Martin  Molecular Cell 
Figure 1 Extrinsic and intrinsic pathways of apoptosis
A possible mechanism of renal cell death after ischemia/reperfusion
Apoptosis: Current Biology
The TNF Receptor 1 Cell Volume 114, Issue 2, Pages (July 2003)
Jeffrey C Rathmell, Craig B Thompson  Cell 
Volume 8, Issue 3, Pages (September 2001)
Sam68 Guest STARs in TNF-α Signaling
The End and After: How Dying Cells Impact the Living Organism
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
“Bak (and Bax) to the Future” — of Primary Melanoma Prognosis?
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
The Many Roles of FAS Receptor Signaling in the Immune System
Presentation transcript:

Volume 44, Issue 1, Pages 9-16 (October 2011) RIPK-Dependent Necrosis and Its Regulation by Caspases: A Mystery in Five Acts  Douglas R. Green, Andrew Oberst, Christopher P. Dillon, Ricardo Weinlich, Guy S. Salvesen  Molecular Cell  Volume 44, Issue 1, Pages 9-16 (October 2011) DOI: 10.1016/j.molcel.2011.09.003 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 A Mysterious Death (A) Schematic of apoptotic death pathways. Extrinsic signals through death receptors like CD95 or intrinsic signals that activate proapoptotic Bcl-2 members like Bid and Bim lead to activation of downstream effector caspases (caspase-3). Loss of proapoptotic molecules lead to a range of phenotypes, including embryonic lethality associated with exencephaly (caspase-9, APAF-1, or caspase-3 knockouts) and lymphoaccumulative and autoimmune disorders (CD95/CD95L or Bim knockout mice). (It should be noted, however, that while cells lacking downstream elements of the mitochondrial pathway do not undergo apoptosis via this route, cells may nevertheless die by a caspase-independent mechanism). Additionally, animals deficient in certain proapoptotic molecules (i.e., Bim or Bax knockouts) display enhanced oncogenesis. Cells from animals where proapoptotic proteins are deleted are generally resistant to apoptosis, while cells from animals missing antiapoptotic proteins (such as Bcl-2 and Bcl-xL) have increased sensitivity to apoptotic stimuli. (B) Ablation of caspase-8 leads to embryonic lethality circa e10.5. The simultaneous deletion of caspase-8 and RIPK3 or FADD together with RIPK1 rescue embryonic development, suggesting that FADD and caspase-8 act in concert to provide survival signals which may inhibit RIPK function during development. Molecular Cell 2011 44, 9-16DOI: (10.1016/j.molcel.2011.09.003) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Caspase 8 and FLIP—the Twins of Death and Protection (A) Caspase-8 consists of a prodomain, followed by the large and the small protease subunits, separated by linker regions. The prodomain has two death “folds” named death effector domains (DEDs, light blue), through which caspase-8 is recruited and dimerized. Upon dimerization, caspase-8 becomes proteolytically active and processes itself in specific cleavage sites present in the linker regions. The cleavage between the large and small subunit contributes to the stabilization of the molecule and is essential to induction of cell death but is dispensable for RIPK-necrosis inhibition. (B) FLIP has a similar structure to that of caspase-8, but it lacks the catalytic cysteine. Although it can act as a dominant negative for caspase-8-induced death when overexpressed, FLIP acts in concert with caspase-8 to inhibit RIPK-induced necrosis. Molecular Cell 2011 44, 9-16DOI: (10.1016/j.molcel.2011.09.003) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Our Protector, but How? Caspase-8-FLIP complex blocks RIPK-dependent necrosis, although the precise mechanism behind this inhibition is still unknown. RIPK1 and RIPK3, as well as upstream deubiquitinase CYLD, are caspase-8 cleavage targets, suggesting that cleavage of any of these proteins might be critical for necrosis inhibition. However, as little is known about what is downstream RIPK1/RIPK3 activation, other targets for caspase-8 may yet be implicated. Molecular Cell 2011 44, 9-16DOI: (10.1016/j.molcel.2011.09.003) Copyright © 2011 Elsevier Inc. Terms and Conditions